Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of Nebivolol Compared With Carvedilol in Patients With Coronary Artery Disease and Stage I or II Hypertension

NCT00673075 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00673075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00673075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of Nebivolol Compared With Carvedilol in Patients With Coronary Artery Disease and Stage I or II Hypertension
Lead sponsor
Forest Laboratories
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2008
Completion date
Not reported
Enrollment
39 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, hypertension